Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
OAZ1 pseudogene 1 (OAZ1P1) is classified as a pseudogene and not a functional protein-coding gene or canonical molecule/receptor. Pseudogenes, by definition, resemble known genes but are typically non-functional due to mutations, lack of promoters, or inability to be translated into a functional protein. There is no evidence that OAZ1P1 serves as a receptor, enzyme, transporter, or therapeutic target. Canonical OAZ1 (Ornithine decarboxylase antizyme 1) is a well-characterized enzyme regulator involved in polyamine homeostasis and cell proliferation, but the pseudogene variant OAZ1P1 does not fulfill similar biological roles and is not recognized as a target in biomedical research or drug development[1][3][5]. If there is any confusion or misclassification regarding OAZ1P1 as a therapeutic target, it is due to its status as a pseudogene, which are generally not considered valid molecular targets. Note: The query seems to refer to OAZ1P1 as a molecular target, but current knowledge and database entries only recognize the functional OAZ1 gene/protein as a therapeutic or biological target. There is no strong evidence of OAZ1P1 encoding a protein, being involved in disease, serving as a biomarker, or interacting with drugs. This entry is thus marked as "is_incorrect: true" for the context of therapeutic targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on OAZ1 pseudogene 1 (OAZ1P1).